bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+))

C128H90N22OPt5S2 — CID 157325921

IUPACbis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+))
SMILESC(=C1[N-]c2ccccc2N1c1ccccc1)c1cccc(-c2cccc(C=C3[N-]c4ccccc4N3c3ccccc3)n2)n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].[c-]1ccccc1-c1cccc(N(c2ccccc2)c2cccc(-c3[c-]cccc3)n2)n1.[c-]1ccccc1-c1cccc(Oc2cccc(-c3[c-]cccc3)n2)n1.c1ccc(N(c2cccc(-c3nccs3)n2)c2cccc(-c3nccs3)n2)cc1
InChIInChI=1S/C38H26N6.C28H19N3.C22H15N5S2.C22H14N2O.2C9H8N3.5Pt/c1-3-15-29(16-4-1)43-35-23-9-7-19-33(35)41-37(43)25-27-13-11-21-31(39-27)32-22-12-14-28(40-32)26-38-42-34-20-8-10-24-36(34)44(38)30-17-5-2-6-18-30;1-4-12-22(13-5-1)25-18-10-20-27(29-25)31(24-16-8-3-9-17-24)28-21-11-19-26(30-28)23-14-6-2-7-15-23;1-2-6-16(7-3-1)27(19-10-4-8-17(25-19)21-23-12-14-28-21)20-11-5-9-18(26-20)22-24-13-15-29-22;1-3-9-17(10-4-1)19-13-7-15-21(23-19)25-22-16-8-14-20(24-22)18-11-5-2-6-12-18;2*1-7-6-9(12-11-7)8-4-2-3-5-10-8;;;;;/h1-26H;1-12,14,16-21H;1-15H;1-9,11,13-16H;2*2-6H,1H3;;;;;/q2*-2;;-2;2*-1;;4*+2
InChIKeyMIJNTSRMQQKDRP-UHFFFAOYSA-N
MW2991.80 g/mol
LogP31.54
Rot. Bonds21

About bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+))

bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+)) (PubChem CID 157325921) has the molecular formula C128H90N22OPt5S2 and a molecular weight of 2991.80 g/mol. Its IUPAC name is bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+)).

Molecular Properties

Compound Namebis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+))
PubChem CID157325921
Molecular FormulaC128H90N22OPt5S2
Molecular Weight2991.80 g/mol
Exact Mass2989.53
IUPAC Namebis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+))
SMILESC(=C1[N-]c2ccccc2N1c1ccccc1)c1cccc(-c2cccc(C=C3[N-]c4ccccc4N3c3ccccc3)n2)n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].[c-]1ccccc1-c1cccc(N(c2ccccc2)c2cccc(-c3[c-]cccc3)n2)n1.[c-]1ccccc1-c1cccc(Oc2cccc(-c3[c-]cccc3)n2)n1.c1ccc(N(c2cccc(-c3nccs3)n2)c2cccc(-c3nccs3)n2)cc1
InChIInChI=1S/C38H26N6.C28H19N3.C22H15N5S2.C22H14N2O.2C9H8N3.5Pt/c1-3-15-29(16-4-1)43-35-23-9-7-19-33(35)41-37(43)25-27-13-11-21-31(39-27)32-22-12-14-28(40-32)26-38-42-34-20-8-10-24-36(34)44(38)30-17-5-2-6-18-30;1-4-12-22(13-5-1)25-18-10-20-27(29-25)31(24-16-8-3-9-17-24)28-21-11-19-26(30-28)23-14-6-2-7-15-23;1-2-6-16(7-3-1)27(19-10-4-8-17(25-19)21-23-12-14-28-21)20-11-5-9-18(26-20)22-24-13-15-29-22;1-3-9-17(10-4-1)19-13-7-15-21(23-19)25-22-16-8-14-20(24-22)18-11-5-2-6-12-18;2*1-7-6-9(12-11-7)8-4-2-3-5-10-8;;;;;/h1-26H;1-12,14,16-21H;1-15H;1-9,11,13-16H;2*2-6H,1H3;;;;;/q2*-2;;-2;2*-1;;4*+2
InChIKeyMIJNTSRMQQKDRP-UHFFFAOYSA-N
XLogP31.54
TPSA259.05 Ų
H-Bond Donors
H-Bond Acceptors21
Rotatable Bonds21
Heavy Atoms158
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002991.80
LogP ≤ 531.54
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

CID 160012827
CID 160012827
CID 161705901
CID 161705901
N-[3-(3H-1-benzofuran-3-id-2-yl)benzene-2-id-1-yl]-N-phenyl-6-pyrazol-1-ylpyridin-2-amine;N-[3-(3H-1-benzothiophen-3-id-2-yl)benzene-2-id-1-yl]-N-phenyl-6-pyrazol-1-ylpyridin-2-amine;N-[3-(3H-furan-3-id-2-yl)benzene-2-id-1-yl]-N-phenyl-6-pyrazol-1-ylpyridin-2-amine;N-[3-(3H-furan-3-id-4-yl)benzene-2-id-1-yl]-N-phenyl-6-pyrazol-1-ylpyridin-2-amine;N-[3-(2H-indol-2-id-1-yl)benzene-2-id-1-yl]-N-phenyl-6-pyrazol-1-ylpyridin-2-amine;N-phenyl-6-pyrazol-1-yl-N-[3-(2H-pyrrol-2-id-1-yl)benzene-2-id-1-yl]pyridin-2-amine;N-phenyl-6-pyrazol-1-yl-N-[3-(3H-thiophen-3-id-2-yl)benzene-2-id-1-yl]pyridin-2-amine;N-phenyl-6-pyrazol-1-yl-N-[3-(3H-thiophen-3-id-4-yl)benzene-2-id-1-yl]pyridin-2-amine;octakis(platinum(2+))
CID 157251919
CID 157296429
CID 157296429
CID 157304812
CID 157304812
CID 157341324
CID 157341324
CID 157368733
CID 157368733
N-[3-(3,5-dimethylpyrazol-1-yl)-4H-thieno[2,3-b]thiophen-4-id-5-yl]-N-phenyl-6,10-dihydro-5H-benzo[h]quinolin-10-id-9-amine;4-(1-methylbenzimidazol-2-yl)-N-phenyl-N-(3-thieno[3,2-b]pyridin-3-ylbenzene-2-id-1-yl)-3H-1-benzofuran-3-id-2-amine;1-(1-methylimidazol-4-yl)-9-(3-thieno[3,2-d][1,3]thiazol-6-ylbenzene-2-id-1-yl)-10H-thieno[3,2-b]carbazol-10-ide;tetrakis(platinum(2+));7-pyridin-2-yl-5-(3-pyridin-2-ylbenzene-2-id-1-yl)-6H-benzo[b]carbazol-6-ide
CID 157439336
CID 157560433
CID 157560433
CID 157657832
CID 157657832
CID 157979586
CID 157979586
CID 158042935
CID 158042935

Frequently Asked Questions

What is the IUPAC name of bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+))?
The IUPAC name of bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+)) (CID 157325921) is bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+)).
What is the SMILES notation for bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+))?
The canonical SMILES for bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+)) is C(=C1[N-]c2ccccc2N1c1ccccc1)c1cccc(-c2cccc(C=C3[N-]c4ccccc4N3c3ccccc3)n2)n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].[c-]1ccccc1-c1cccc(N(c2ccccc2)c2cccc(-c3[c-]cccc3)n2)n1.[c-]1ccccc1-c1cccc(Oc2cccc(-c3[c-]cccc3)n2)n1.c1ccc(N(c2cccc(-c3nccs3)n2)c2cccc(-c3nccs3)n2)cc1.
What is the InChIKey of bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+))?
The InChIKey is MIJNTSRMQQKDRP-UHFFFAOYSA-N. The full InChI is InChI=1S/C38H26N6.C28H19N3.C22H15N5S2.C22H14N2O.2C9H8N3.5Pt/c1-3-15-29(16-4-1)43-35-23-9-7-19-33(35)41-37(43)25-27-13-11-21-31(39-27)32-22-12-14-28(40-32)26-38-42-34-20-8-10-24-36(34)44(38)30-17-5-2-6-18-30;1-4-12-22(13-5-1)25-18-10-20-27(29-25)31(24-16-8-3-9-17-24)28-21-11-19-26(30-28)23-14-6-2-7-15-23;1-2-6-16(7-3-1)27(19-10-4-8-17(25-19)21-23-12-14-28-21)20-11-5-9-18(26-20)22-24-13-15-29-22;1-3-9-17(10-4-1)19-13-7-15-21(23-19)25-22-16-8-14-20(24-22)18-11-5-2-6-12-18;2*1-7-6-9(12-11-7)8-4-2-3-5-10-8;;;;;/h1-26H;1-12,14,16-21H;1-15H;1-9,11,13-16H;2*2-6H,1H3;;;;;/q2*-2;;-2;2*-1;;4*+2.
What are the key properties of bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+))?
bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+)) has a molecular weight of 2991.80 g/mol, XLogP of 31.54, 21 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for bis(2-(5-methylpyrazol-2-id-3-yl)pyridine);1-phenyl-2-[[6-[6-[(1-phenylbenzimidazol-3-id-2-ylidene)methyl]-2-pyridinyl]-2-pyridinyl]methylidene]benzimidazol-3-ide;N-phenyl-6-phenyl-N-(6-phenyl-2-pyridinyl)pyridin-2-amine;2-phenyl-6-[(6-phenyl-2-pyridinyl)oxy]pyridine;N-phenyl-6-(1,3-thiazol-2-yl)-N-[6-(1,3-thiazol-2-yl)-2-pyridinyl]pyridin-2-amine;platinum;tetrakis(platinum(2+)) is sourced from PubChem (CID 157325921), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).